ClinConnect ClinConnect Logo
Search / Trial NCT06699823

Validation of the Greek Postoperative Quality of Recovery Score 15

Launched by IASO THESSALIAS · Nov 19, 2024

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Quality Of Recovery Patient Reported Outcomes Qo R 15 Validation Cultural Adaptation

ClinConnect Summary

This clinical trial is focused on making sure a questionnaire that helps measure how well patients recover after surgery is useful for Greek-speaking patients. The study will translate the original questionnaire into Greek and check if it works well, is easy to understand, and can be used comfortably by patients after their surgeries. The aim is to ensure that this tool accurately reflects patients' recovery experiences so that healthcare providers can better support them.

To be eligible for this study, participants should be over 18 years old and scheduled for elective (planned) general surgery where they will be put under general anesthesia. Unfortunately, people who are having emergency surgeries, have trouble understanding Greek, or have certain medical conditions that may affect their ability to participate won’t be included. If you join the study, you will help researchers understand how to better evaluate recovery in Greek-speaking patients, which could improve care in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age\>18 years old
  • Scheduled elective general surgery under general anesthesia
  • Exclusion Criteria:
  • Emergency surgery
  • Poor Greek comprehension
  • Inability to give consent
  • A psychiatric or neurological condition that precludes cooperation
  • Known history of alcohol or drug dependence
  • Life-threatening postoperative complications
  • Postoperative admission to ITU

About Iaso Thessalias

IASO Thessalias is a leading clinical trial sponsor dedicated to advancing medical research and innovation. Based in Thessaly, Greece, the organization specializes in the development and management of clinical trials across various therapeutic areas, including oncology, cardiology, and neurology. Committed to rigorous scientific standards and ethical practices, IASO Thessalias collaborates with healthcare professionals, research institutions, and pharmaceutical companies to ensure the successful execution of clinical studies. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, IASO Thessalias plays a vital role in the advancement of healthcare solutions.

Locations

Larissa, Thessaly, Greece

Patients applied

0 patients applied

Trial Officials

DESPOINA LIOTIRI, ANAESTHESIOLOGIST

Principal Investigator

IASO THESSALIAS GENERAL HOSPITAL

DIMITRIOS ZACHAROULIS, PROFESSOR OF SURGERY

Study Chair

University of Thessaly

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported